1. Home
  2. RITM vs GRFS Comparison

RITM vs GRFS Comparison

Compare RITM & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rithm Capital Corp.

RITM

Rithm Capital Corp.

HOLD

Current Price

$10.17

Market Cap

5.4B

Sector

Real Estate

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.38

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RITM
GRFS
Founded
2011
1940
Country
United States
Spain
Employees
6045
25247
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RITM
GRFS
Price
$10.17
$8.38
Analyst Decision
Strong Buy
Hold
Analyst Count
9
2
Target Price
$14.06
$10.15
AVG Volume (30 Days)
7.2M
623.6K
Earning Date
04-28-2026
07-28-2022
Dividend Yield
9.83%
1.70%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.69
Revenue Next Year
$28.68
$6.49
P/E Ratio
$10.21
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$8.43
$6.90
52 Week High
$12.74
$11.14

Technical Indicators

Market Signals
Indicator
RITM
GRFS
Relative Strength Index (RSI) 60.11 51.37
Support Level $9.41 $8.27
Resistance Level $11.24 $9.78
Average True Range (ATR) 0.21 0.19
MACD 0.07 0.05
Stochastic Oscillator 89.60 53.61

Price Performance

Historical Comparison
RITM
GRFS

About RITM Rithm Capital Corp.

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: